Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 18 | 2024 | 3200 | 2.230 |
Why?
|
Kidney Neoplasms | 15 | 2024 | 4303 | 1.640 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2023 | 450 | 0.900 |
Why?
|
Wilms Tumor | 1 | 2022 | 379 | 0.640 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 567 | 0.530 |
Why?
|
Carcinoma, Papillary | 1 | 2020 | 793 | 0.480 |
Why?
|
Carcinoma | 2 | 2023 | 2341 | 0.480 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13576 | 0.460 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 325 | 0.320 |
Why?
|
Pathology, Clinical | 2 | 2024 | 376 | 0.300 |
Why?
|
Papillomavirus Infections | 4 | 2020 | 1640 | 0.270 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3939 | 0.270 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 1141 | 0.270 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5443 | 0.250 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1614 | 0.240 |
Why?
|
Octamer Transcription Factors | 1 | 2023 | 18 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 699 | 0.220 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.210 |
Why?
|
Indans | 1 | 2022 | 92 | 0.190 |
Why?
|
Biology | 1 | 2023 | 292 | 0.190 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 1105 | 0.180 |
Why?
|
Paris | 1 | 2020 | 41 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3666 | 0.170 |
Why?
|
Head and Neck Neoplasms | 3 | 2019 | 2923 | 0.170 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 256 | 0.170 |
Why?
|
Sulfones | 1 | 2022 | 448 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2023 | 8634 | 0.160 |
Why?
|
Anilides | 1 | 2022 | 414 | 0.160 |
Why?
|
In Situ Hybridization | 2 | 2019 | 1905 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 998 | 0.150 |
Why?
|
Mutation | 3 | 2024 | 30228 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2020 | 249 | 0.140 |
Why?
|
Abdomen | 1 | 2023 | 1136 | 0.140 |
Why?
|
Pancreas | 1 | 2023 | 1702 | 0.130 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1395 | 0.130 |
Why?
|
Gene Dosage | 1 | 2020 | 1221 | 0.130 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2018 | 493 | 0.130 |
Why?
|
Humans | 31 | 2024 | 768393 | 0.120 |
Why?
|
Immunotherapy | 3 | 2021 | 4738 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1508 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2524 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5422 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1167 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4646 | 0.110 |
Why?
|
Papillomavirus Vaccines | 1 | 2020 | 497 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11120 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4069 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2018 | 1140 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4120 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1807 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1597 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2046 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2952 | 0.090 |
Why?
|
Transcription Factors | 4 | 2023 | 12166 | 0.090 |
Why?
|
Histone Demethylases | 2 | 2023 | 322 | 0.090 |
Why?
|
Gene Fusion | 2 | 2024 | 356 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3112 | 0.090 |
Why?
|
Pyridines | 1 | 2022 | 2889 | 0.080 |
Why?
|
RNA, Viral | 1 | 2018 | 2866 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 17135 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3543 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2044 | 0.070 |
Why?
|
Epigenomics | 2 | 2023 | 959 | 0.070 |
Why?
|
Forkhead Transcription Factors | 2 | 2024 | 1623 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16721 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11254 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3804 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 710 | 0.060 |
Why?
|
Lung | 1 | 2023 | 10089 | 0.060 |
Why?
|
Male | 11 | 2024 | 364902 | 0.060 |
Why?
|
Giant Cells | 1 | 2024 | 187 | 0.060 |
Why?
|
Prognosis | 5 | 2024 | 30022 | 0.060 |
Why?
|
Female | 12 | 2024 | 397089 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59686 | 0.060 |
Why?
|
Aged | 7 | 2024 | 171562 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18048 | 0.050 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2022 | 305 | 0.040 |
Why?
|
Fumarate Hydratase | 1 | 2020 | 55 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 223491 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2024 | 81801 | 0.040 |
Why?
|
Angiomyolipoma | 1 | 2020 | 189 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 560 | 0.040 |
Why?
|
France | 1 | 2019 | 497 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54920 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1235 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 755 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2023 | 1277 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2024 | 2886 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22385 | 0.030 |
Why?
|
Education, Distance | 1 | 2019 | 261 | 0.030 |
Why?
|
Child | 1 | 2023 | 80891 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223640 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1883 | 0.030 |
Why?
|
Adolescent | 1 | 2022 | 89184 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3623 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3520 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2968 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1885 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2986 | 0.020 |
Why?
|
DNA, Viral | 1 | 2018 | 2205 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14737 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6541 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 3431 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3587 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2412 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20224 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5796 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5708 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9063 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9614 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11854 | 0.010 |
Why?
|
Animals | 2 | 2023 | 169337 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82017 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41795 | 0.010 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_